Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonia I Skarlatos

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Human Gene Therapy|September 15, 2012
Center for fetal monkey gene transfer for heart, lung, and blood diseases: an NHLBI resource for the gene therapy communityAlice F Tarantal, Sonia I Skarlatos
Circulation Research|April 27, 2013
National Heart, Lung, and Blood Institute and the translation of cardiovascular discoveries into therapeutic approachesZorina S Galis, Jodi B Black, Sonia I Skarlatos
American Heart Journal|April 13, 2004
Report of the National Heart, Lung and Blood Institute-National Institute of Allergy and Infectious Diseases working group on antimicrobial strategies and cardiothoracic surgeryFranklin D Lowy, John A Waldhausen, Marissa Miller, et al.
Contemporary Clinical Trials|May 28, 2011
Oversight and management of a cell therapy clinical trial network: experience and lessons learnedLemuel A Moyé, Shelly L Sayre, Lynette Westbrook, et al.
Human Gene Therapy. Clinical Development|May 23, 2013
Advancing translational research through the NHLBI Gene Therapy Resource Program (GTRP)Cheryl L McDonald, Janet Benson, Kenneth Cornetta, et al.
Journal of Cardiovascular Translational Research|May 7, 2010
Development of a network to test strategies in cardiovascular cell delivery: the NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN)Robert D Simari, Lemuel A Moyé, Sonia I Skarlatos, et al.
Transfusion|February 11, 2012
Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) studySara Richman, Adrian P Gee, David H McKenna, et al.
Human Gene Therapy|March 23, 2013
Gene therapy for rare diseases: summary of a National Institutes of Health workshop, September 13, 2012Marina O'Reilly, Donald B Kohn, Jeffrey Bartlett, et al.
American Heart Journal|August 10, 2010
Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and designJames T Willerson, Emerson C Perin, Stephen G Ellis, et al.
Texas Heart Institute Journal|September 17, 2010
LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarctionJay H Traverse, Timothy D Henry, Douglas E Vaughan, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Human Gene Therapy|September 15, 2012
Center for fetal monkey gene transfer for heart, lung, and blood diseases: an NHLBI resource for the gene therapy communityAlice F Tarantal, Sonia I Skarlatos
Circulation Research|April 27, 2013
National Heart, Lung, and Blood Institute and the translation of cardiovascular discoveries into therapeutic approachesZorina S Galis, Jodi B Black, Sonia I Skarlatos
American Heart Journal|April 13, 2004
Report of the National Heart, Lung and Blood Institute-National Institute of Allergy and Infectious Diseases working group on antimicrobial strategies and cardiothoracic surgeryFranklin D Lowy, John A Waldhausen, Marissa Miller, et al.
Contemporary Clinical Trials|May 28, 2011
Oversight and management of a cell therapy clinical trial network: experience and lessons learnedLemuel A Moyé, Shelly L Sayre, Lynette Westbrook, et al.
Human Gene Therapy. Clinical Development|May 23, 2013
Advancing translational research through the NHLBI Gene Therapy Resource Program (GTRP)Cheryl L McDonald, Janet Benson, Kenneth Cornetta, et al.
Journal of Cardiovascular Translational Research|May 7, 2010
Development of a network to test strategies in cardiovascular cell delivery: the NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN)Robert D Simari, Lemuel A Moyé, Sonia I Skarlatos, et al.
Transfusion|February 11, 2012
Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) studySara Richman, Adrian P Gee, David H McKenna, et al.
Human Gene Therapy|March 23, 2013
Gene therapy for rare diseases: summary of a National Institutes of Health workshop, September 13, 2012Marina O'Reilly, Donald B Kohn, Jeffrey Bartlett, et al.
American Heart Journal|August 10, 2010
Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and designJames T Willerson, Emerson C Perin, Stephen G Ellis, et al.
Texas Heart Institute Journal|September 17, 2010
LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarctionJay H Traverse, Timothy D Henry, Douglas E Vaughan, et al.
Pageof 2